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Abstract 
 
Acute appendicitis, while common in younger patients, is an unusual cause for 
hospitalization among older adults. We report a case series of 3 individuals who 
had been previously implanted with a continuous-flow left ventricular assist device 
(CFLVAD) for end-stage heart failure, and who subsequently developed acute 
appendicitis. Both axial-flow technology and nonpulsatile systemic blood flow have 
been implicated as potential causes for bleeding and thrombosis in contemporary 
LVAD populations (13). This case series represents the first report of acute 
appendicitis as an adverse event following LVAD implantation and represents a 
patient demographic that would historically be at very low-risk for this illness. Our 
patients, their presentation, and the associated pathologic findings raise the 
possibility of a unique link between appendiceal inflammation and CFLVAD 
support that warrants attention. 
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Introduction 
 
Acute appendicitis is common and affects nearly one-quarter of a million 
Americans per year. It most often presents in patients between the ages of 10 and 
19 years, with an overall rate of 235,000 cases/year in this demographic cohort 
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(4). We describe 3 unique cases of acute appendicitis that occurred in patients 
who had previously received a HeartMate II (Thoratec Corporation) LVAD (n=177) 
for management of end-stage systolic heart failure at our institution. The affected 
patients in our series ranged in age from 51 to 62 years – a demographic 
historically associated with a very low incidence of appendicitis (approximately 56 
cases per 10,000 patients per year) (4). Although the cohort is small, we felt that 
the incidence is epidemiologically intriguing. This unusual cohort of patients raises 
the possibility that there may be a pathophysiological interaction between 
continuous systemic blood flow, axial-flow technology, and the subsequent 
development of appendiceal inflammation. 
 
Case Presentation 
 
The first patient was a 62 year old female with a past medical history of severe, 
chronic systolic heart failure, type II diabetes mellitus, chronic kidney disease, and 
hypertension who underwent LVAD placement with a HeartMate II (HM-II) axial-
flow device. Prior to admission, the patient had a history of GI bleeding that was 
not characterized with EGD due to high risk of the procedure. Greater than 3 years 
after LVAD implantation, she presented to the Emergency Department (ED) with 
the acute onset of nausea, vomiting, and abdominal pain. The patient’s exam was 
significant for pain localized to the right lower quadrant, with associated guarding 
and rebound tenderness. Her bowel sounds were diminished. Her laboratory 
analysis was notable for a leukocytosis (white blood cell count, WBC = 20.6 
10*9/L). Her creatinine was stable at 2.41 mg/dL. A serum pro-B-type natriuretic 
peptide (proBNP) was elevated at 44,700 pg/mL. Lactate dehydrogenase (LDH) 
was stable at 768 U/L (normal 338610 U/L) and international normalized ratio 
(INR) was 2.0. Interrogation of her LVAD revealed settings of: flow 5.4, speed 
9800 RPM (goal average speed in our population is 900010000), pulsatility index 
(PI) 6.4, and power 7.0. Unfortunately there was no echocardiographic or 
hemodynamic data available just prior to surgery. However, the patient’s previous 
echo showed left ventricular hypertrophy with an ejection fraction of 45%, trivial 
mitral regurgitation, mild aortic regurgitation, mild pulmonary regurgitation and 
normal right ventricular performance. Both a urinalysis and blood cultures were 
obtained before the patient was started empirically on IV piperacillin-tazobactam 
(Zosyn) for broad-spectrum antimicrobial therapy. Given her persistent abdominal 
pain, a computed tomography (CT) scan was ordered. This revealed a ruptured 
appendix with a small area of peri-appendiceal gas and nearby fluid collection 
concerning for possible abscess. The patient’s antimicrobial therapy was then 
broadened, and an emergent surgical consultation was requested. After evaluating 
the patient, the surgical team recommended percutaneous abscess drainage with 
plans to perform definitive appendectomy following patient stabilization. A drain 
was placed into the abscess approximately 2 days following admission to the 
hospital, and output was closely monitored. After transitioning to an oral 
antimicrobial regimen (including levofloxacin and metronidazole), the patient was 
discharged to home. Two weeks later, the drain was removed and the patient 
remained on antibiotics until the time of appendectomy, approximately 2 months 
later. At the time of removal, the appendix was described pathologically as having 
“submucosal fibrosis and fibrous scarring of the muscularis propria and peri-
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appendiceal soft tissue, consistent with a prior episode of appendicitis.” The 
patient tolerated the surgery well and made a full recovery. 
 
The second patient was a 51 year old male with a past medical history of 
hypertension, hyperlipidemia, and end-stage systolic heart failure who received a 
HMII LVAD approximately 2 months prior to his presentation with acute 
appendicitis. The patient initially presented to the LVAD clinic with three days of 
worsening nausea, vomiting, and abdominal pain. His exam was significant for 
marked tenderness to palpation at McBurney’s point and he was sent to the ED for 
further evaluation. There, he received a CT scan that showed an enlarged 
appendix with wall thickening, hyperenhancement, and periappendiceal 
inflammatory stranding. There was no free air surrounding the appendix or 
radiographic evidence of abscess formation. His laboratory values were significant 
for a normal WBC count of 5.8 10*9/L and INR of 2.5. Other significant laboratory 
values for this patient included an LDH of 1461 U/L and rose to 2122 U/L during 
hospitalization, proBNP of 1640 pg/mL, and total bilirubin of 1.9 mg/dL. LVAD 
settings showed flow 3.7, speed 8200 RPM, PI 5.8, and power not recorded. 
Echocardiogram at the time of admission showed mild contractile left ventricular 
dysfunction with an ejection fraction of 45%, elevated left ventricular pressures, 
dilated right atrium with a normal right ventricular contractile performance. The 
patient received 2 units of fresh frozen plasma to reverse the coagulopathy 
associated with his chronic Coumadin use, and he subsequently underwent urgent 
laparoscopic appendectomy. There were no complications with the surgery. 
Pathology showed a “7.1 cm long x 0.6 cm in diameter diffusely disrupted and torn 
vermiform appendix, along with a 2.5 x 1.2 x 0.4 cm aggregate of soft gray/tan 
tissue and red/brown blood clot. The serosa was gray and scabrous. The margin 
was inked green, and the wall was 0.1 cm thick. The lumen was patent with a 
red/brown mucosa.” In summary, these findings were consistent with the patient’s 
clinical diagnosis of acute appendicitis. He was treated with IV Meropenem and 
then transitioned to levofloxacin and metronidazole at discharge to complete a 14-
day oral antibiotic course. The patient made a full recovery and was later 
transplanted. 
The final patient was a 65 year old female with a past medical history of end-stage 
systolic heart failure, hypertension, and chronic kidney disease who was 
transplant-ineligible and therefore had a HM-II LVAD placed as destination 
therapy. The patient did have a history of bleeding and was started on thalidomide 
out of concern for angiodysplasia. Following 3.5 years of uncomplicated LVAD 
support, the patient began to notice low grade fevers. These symptoms persisted 
for 3-4 days and were associated with chills, fatigue, and generalized weakness. 
The patient also endorsed one week of right lower quadrant and epigastric 
abdominal pain that was sharp and non-radiating. Upon further questioning, she 
noted nausea and vomiting, decreased appetite, and diminished oral intake. With 
ongoing symptoms, the patient then presented to her primary doctor who 
prescribed oral Cephalexin to treat a presumed urinary tract infection. When this 
did little to alleviate her pain, she then presented to the ED for additional 
evaluation. Her laboratory studies there were significant for a neutrophil-
predominant WBC count of 20.1 10*9/L, serum creatinine of 1.21 mg/dL, normal 
liver function tests, a proBNP 4680 pg/mL (increased from previous value of 388 
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two weeks earlier), INR 1.5, LDH was stable at 739 U/L (normal 338610 U/L) but 
rose during admission to 2411 U/L, and a venous lactate of 1.3 mmol/L. LVAD 
settings for her were flow 4.0, speed 9400 RPM, PI 3.9, power 5.6. 
Echocardiogram two weeks before presentation showed left ventricular 
hypertrophy with severe contractile dysfunction and ejection fraction of 25%, aortic 
sclerosis, degenerative mitral valve disease, and mild right ventricular dysfunction. 
No echo was done at the time of presentation. 
 
She was started on IV Vancomycin, which was then changed to IV levofloxacin 
and metronidazole following hospital admission. A CT scan revealed acute 
appendicitis without evidence of perforation. The patient underwent an open 
appendectomy due to concerns that pneumoperitoneum, as part of a laparoscopic 
surgery, might lead to hemodynamic instability. 
 
The patient’s postoperative course was complicated by an adynamic ileus that 
resolved after six days of bowel rest. Surgical pathology of tissue fragments 
showed “a 5.5 x 0.6 cm tubular fragment of dark red/tan tissue with a dark 
red/purple external surface and no evidence of exudate or disruption. The 
presumed appendiceal tip was identified at one end. Sectioning revealed a patent 
lumen with markedly hemorrhagic wall”. She remained on oral antibiotics for one 
month following discharge from the hospital. She made a full recovery and is still 
on LVAD support at this time. 
 
Discussion  
Acute appendicitis, while common among children, teenagers, and young adults, is 
considerably less common among older patients. While more recent epidemiologic 
data has suggested that rates among those 50-69 years old have begun to slowly 
increase over time (5) owing to longer patient lifespans and better diagnostic tools 
- the development of appendicitis in 3 out of 177 of our HeartMate II LVAD patients 
would be considered epidemiologically unusual (Figure 1). Unfortunately, there 
was no data while reviewing the epidemiology of appendicitis incidence that details 
how many of these patients suffered from heart failure, hypertension, diabetes, 
stroke or other medical chronic medical conditions therefore statistical 
comparisons between these groups could not be performed. This unexpected 
finding raises the possibility of a pathophysiologic link between CF-LVAD support 
and the development of appendiceal injury.  
 
It has been previously demonstrated that patients with CF-LVADs have increased 
circulating markers of inflammation. This is thought to be due to blood-device 
interactions and the influence of continuous (as opposed to pulsatile) blood flow 
(6). It is also known that acquired von Willebrand Deficiency (vWD) (7) and 
angiodysplasias (1) - each well-described complications of axial-flow LVADs – can 
lead to intestinal ischemia. The pathogenesis of angiodysplasias in the 
gastrointestinal tracts are not fully understood. The imbalance of proangiogenic 
and antiangiogenic factors plays a large role. The leading cause is thought to be 
venous congestion caused by low output states (as in patient with LVADs) in the 
submucosa that is translated to capillary congestion and formation of 
arteriovenous collaterals through increased VEGF secretion (8). In addition, these 
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angiodysplastic changes are most commonly found in the peri-appendiceal portion 
of the gastrointestinal tract (9). LVADs are known to lead to arteriovenous 
 
 
 
 
 
Figure 1         
Incidence of appendicitis in 50-69 year olds 
 
malformations (10) and are known to occur more frequently in patients without 
pulsatile flow. One could then postulate that the combined effects of enhanced 
systemic inflammation and ischemia arising from the low, non-pulsatile flow state 
combined  with venous congestion, acquired vWD, and formation of arteriovenous 
malformations could lead to a lower threshold for the sudden development of acute 
appendicitis (Figure 2) in the setting of intraluminal obstruction. This has been 
demonstrated in case reports of children that have presented with acute 
appendicitis and were later revealed to have arteriovenous malformations (11, 12). 
Further supporting this notion is the fact that each of the patients described above 
US population Cumulative LVAD 
population of UNC 
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had a documented history of gastrointestinal bleeding after CF-LVAD implantation. 
Due to the high risk nature of further procedures in patients with LVADs, 
esophagogastroduodenoscopy was not performed for any of the patients and they 
were managed conservatively with discontinuation of anticoagulation. In each of 
the cases, the bleeding resolved with this intervention. In summary, although we 
have proposed a model for this, fully developing the pathophysiological model 
would likely require more data from patients in this population. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 
Proposed pathogenesis of acute appendicitis in LVAD 
 
We believe that this is the first reported case series of acute appendicitis following 
implantation of a CF-LVAD, and adds to a growing list of potential adverse events 
among patients supported with these durable devices. While certainly not as 
common as bleeding, thrombosis, driveline infection, or arrhythmias, appendicitis 
should not be considered a benign complication. Management almost always 
requires operative intervention, and this increases the risk for driveline injury, 
sepsis, bleeding, and death among these high-risk individuals. In addition, the 
need to discontinue and even reverse systemic anticoagulation for preoperative 
preparation also puts the device and patient at risk for thrombotic complications, 
including LVAD malfunction, hemolysis, and stroke. As the volume of LVAD 
implants continues to escalate, a better understanding of the potential mechanism 
  
 
 
The VAD Journal: http://dx.doi.org/10.13023/VAD.2016.17 Page 7 of 8 
 
The VAD Journal: The journal of mechanical assisted circulation and heart failure 
of appendiceal injury and an increased awareness of the potential link between 
LVADs and the subsequent development of acute appendicitis is warranted. 
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